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Abstract 
Background: Depletion of cellular antioxidants can result from free radical 
formation due to normal endogenous reactions and the ingestion of exogenous 
substances and environmental factors. The levels of reactive oxygen species (ROS) 
have been shown to be significantly altered in malignant cells and in primary cancer 
tissues. We undertook the present study to investigate the possible alteration of 
oxidant/antioxidant status in Algerian patients with benign prostatic hyperplasia 
(BPH) and prostate cancer (PCa). 
Methods: In total, 89 subjects made up of 26 patients with non-metastatic prostate 
cancer, 31 with benign prostatic hyperplasia (BPH), and 32 controls participated in 
this study. The concentrations of plasmatic malondialdehyde (MDA), erythrocytes 
catalase activity (CAT), and the plasma glutathione levels (GSH) were estimated 
using standard procedures. 
Results: The results showed that MDA concentrations were significantly increased 
while erythrocyte catalase activity was significantly decreased in the prostate 
cancer group versus controls (P < 0.01) and BPH group (P < 0.05). GSH levels 
were lowered in prostate cancer patients versus control group with no significant 
changes. 
Conclusions: Our results suggest that an alteration in the lipid peroxidation index 
with concomitant changes in the antioxidant defense system in prostate cancer 
patients compared with controls. We hypothesize that an altered pro-oxidant–
antioxidant balance may lead to an increase in oxidative damage and consequently 
may play an important role in prostate carcinogenesis. 
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